InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Ginascol John F, Dirigeant. Officer active across 1 companies, notably Abbott Laboratories. In total, 7 disclosures have been published. The latest transaction was disclosed on 3 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€193,2441,768 shares@ €109.30080.0001% mcap4.0% of flow
Common shares without par value
SEC:0001415889-22-006223:0·
€643,3045,876 shares@ €109.47980.0003% mcap13.3% of flow
Common shares without par value
SEC:0001415889-22-002193:0·
017,247 shares0
Common shares without par value
SEC:0001415889-22-001738:0·
€2m45,709 shares@ €40.51680.0009% mcap92.2% of flow
Common shares without par value
SEC:0001415889-21-004998·
€2m45,709 shares@ €40.51680.0009% mcap38.2% of flow
Common shares without par value
SEC:0001415889-21-004998:0·
€155,7731,768 shares@ €88.10680.0001% mcap7.8% of flow
Common shares without par value
SEC:0001415889-21-002830·
€155,7731,768 shares@ €88.10680.0001% mcap3.2% of flow
Common shares without par value
SEC:0001415889-21-002830:0·
7 of 7 declarations
About Ginascol John F
John F. Ginascol serves as Executive Vice President at ABBOTT LABORATORIES. He is responsible for implementing operational strategies to enhance the company's efficiency. His role is essential to ensure Abbott remains competitive in the healthcare sector.
